For citations:
Alekseev BY, Shevchuk IM, Aleshin VР. The use of a new combination of avelumab + axitinib in patients with metastatic kidney cancer in the first line of treatment. Meditsinskiy sovet = Medical Council. 2021;(4S):34-43. (In Russ.) https://doi.org/10.21518/2079-701X-2021-4S-34-43